BR9506552A - Método de inibição de integrase retroviral - Google Patents

Método de inibição de integrase retroviral

Info

Publication number
BR9506552A
BR9506552A BR9506552A BR9506552A BR9506552A BR 9506552 A BR9506552 A BR 9506552A BR 9506552 A BR9506552 A BR 9506552A BR 9506552 A BR9506552 A BR 9506552A BR 9506552 A BR9506552 A BR 9506552A
Authority
BR
Brazil
Prior art keywords
bis
retroviral integrase
amidino
benzimidazolyl
inhibition method
Prior art date
Application number
BR9506552A
Other languages
English (en)
Inventor
Christine Carr Dykstra
Ronald Ivar Swanstrom
Richard Ray Tidwell
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of BR9506552A publication Critical patent/BR9506552A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thin Film Transistor (AREA)
  • Saccharide Compounds (AREA)
  • Recrystallisation Techniques (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Metal-Oxide And Bipolar Metal-Oxide Semiconductor Integrated Circuits (AREA)
BR9506552A 1994-01-20 1995-01-18 Método de inibição de integrase retroviral BR9506552A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/185,079 US6815461B1 (en) 1994-01-20 1994-01-20 Method of inhibiting retroviral integrase
PCT/US1995/000504 WO1995019772A1 (en) 1994-01-20 1995-01-18 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase

Publications (1)

Publication Number Publication Date
BR9506552A true BR9506552A (pt) 1997-10-28

Family

ID=22679488

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506552A BR9506552A (pt) 1994-01-20 1995-01-18 Método de inibição de integrase retroviral

Country Status (11)

Country Link
US (1) US6815461B1 (pt)
EP (1) EP0739202B1 (pt)
JP (1) JP3306830B2 (pt)
AT (1) ATE174508T1 (pt)
AU (1) AU675386B2 (pt)
BR (1) BR9506552A (pt)
CA (1) CA2179015C (pt)
DE (1) DE69506686T2 (pt)
ES (1) ES2128043T3 (pt)
NZ (2) NZ335226A (pt)
WO (1) WO1995019772A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562854B2 (en) 1994-12-14 2003-05-13 Axys Pharmaceuticals, Inc. Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
US6255091B1 (en) 1995-04-28 2001-07-03 Axys Pharmaceuticals, Inc. Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions
CA2281927C (en) 1997-02-25 2004-01-27 Christopher J. Michejda Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
US5935982A (en) * 1997-02-28 1999-08-10 The University Of North Carolina At Chapel Hill Methods of treating retroviral infection and compounds useful therefor
JP2001519806A (ja) * 1997-04-07 2001-10-23 アクシス ファーマシューティカルズ，インコーポレイティド セリンプロテアーゼ活性、特にトリプターゼ活性に関連する疾病を処理するための化合物及び組成物
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
WO1999026933A1 (en) * 1997-11-26 1999-06-03 Axys Pharmaceuticals, Inc. Substituted amidinoaryl derivatives and their use as anticoagulants
PL343424A1 (en) 1998-04-10 2001-08-13 Japan Tobacco Inc Amidine compounds
US7276333B1 (en) 1999-05-13 2007-10-02 Japan Science And Technology Agency Viral infection inhibitor targeting integrase N-terminal domain
US6541486B1 (en) 1999-06-04 2003-04-01 Elan Pharma International Ltd. Bis-benzimidazole compounds and analogs thereof for inhibiting cell death
AU1450401A (en) * 1999-11-01 2001-05-14 Auburn University Methods and formulations for the treatment of infectious bursal disease in avian subjects
US6774144B1 (en) 1999-11-01 2004-08-10 The University Of North Carolina At Chapel Hill Methods and formulations for the treatment of infectious bursal disease in avian subjects
US7262223B2 (en) 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
US7999001B2 (en) * 2007-01-15 2011-08-16 The United States Of America As Represented By The Secretary Of The Army Antiviral compounds and methods of using thereof
US8207209B2 (en) * 2007-10-24 2012-06-26 Functional Genetics, Inc. Methods of inhibiting viral infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA708089B (en) * 1969-12-29 1971-08-25 Abbott Lab Bis-benzimidazole derivatives
US4619942A (en) * 1982-04-08 1986-10-28 University Of North Carolina Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds
US4933347A (en) 1988-10-25 1990-06-12 University Of North Carolina At Chapel Hill Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia
US4963589A (en) 1988-10-25 1990-10-16 The University Of North Carolina At Chapel Hill Methods for treating Giardia lamblia
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
AU7661594A (en) 1993-09-22 1995-04-10 Glaxo Wellcome House Bis(amidinobenzimidazolyl)alkanes as antiviral agents

Also Published As

Publication number Publication date
CA2179015C (en) 2003-06-24
CA2179015A1 (en) 1995-07-27
US6815461B1 (en) 2004-11-09
DE69506686T2 (de) 1999-07-22
EP0739202B1 (en) 1998-12-16
DE69506686D1 (de) 1999-01-28
NZ335226A (en) 2000-11-24
AU675386B2 (en) 1997-01-30
AU1679895A (en) 1995-08-08
NZ279619A (en) 1999-09-29
ATE174508T1 (de) 1999-01-15
JP3306830B2 (ja) 2002-07-24
ES2128043T3 (es) 1999-05-01
JPH09508369A (ja) 1997-08-26
WO1995019772A1 (en) 1995-07-27
EP0739202A1 (en) 1996-10-30

Similar Documents

Publication Publication Date Title
BR9506552A (pt) Método de inibição de integrase retroviral
ES2147836T3 (es) Derivados de 4,5-diariloxazol.
NZ325449A (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
RU94036758A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома
EA199800141A1 (ru) Гетероциклические соединения
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
ES2120728T3 (es) Inhibidores de la agregacion de plaquetas.
RU94044454A (ru) Ингибитор аутоимунных заболеваний
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
ES2154669T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
DE69905144D1 (de) N,N'-Diacylthiocystine
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
GB9323404D0 (en) Pharmaceuticals
CO5011088A1 (es) Fosfato de tetrahidrofurano antifungal
EP0760375A4 (en) Antitumor indolopyprolocarbazole derivative
GB9504497D0 (en) Pharmaceuticals

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal